Talipexole
Appearance
Clinical data | |
---|---|
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
| |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H15N3S |
Molar mass | 209.31 g/mol g·mol−1 |
3D model (JSmol) | |
|
Talipexole is a dopamine agonist that has been proposed as an antiparkinsonian agent.[1] It also has alpha-adrenergic agonist activity.
References
- ^ Kitamura Y, Kosaka T, Kakimura JI; et al. (1998). "Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells". Mol. Pharmacol. 54 (6): 1046–54. PMID 9855633.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link)